To view or add a comment, sign in Lilly's Triple Agonist, Retatrutide, Shines in First Phase 3 Trial Retatrutide is a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist
Not faster, but more stable
The presence of T2D is a negative moderator of the effects of some treatments, such as MBS, on body weight reduction 48
obesitymedicine.org Mass General Brigham Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss advances.massgeneral.org
The enzymes that should support healthy turnover begin destroying the extracellular matrix around your follicles
Many individuals notice improvements in their skins appearance, with reduced wrinkles, better complexion, and a youthful glow